Respiratory Medicine
Volume 103, Issue 6 , Pages 935-938, June 2009

Expression of blood dendritic cell antigens (BDCAs) by CD1a+ human pulmonary cells

  • Maria Tsoumakidou

      Affiliations

    • Lung Pathology Unit, London SW3 6LY, UK
    • Corresponding Author InformationCorresponding author at: Department of Critical Care Medicine and Pulmonary Services, Evangelismos Hospital, Ipsilantou Street 45-7, Athens 10676, Greece. Tel.: +30 3 210 720 1227.
  • ,
  • Sarah J. Kemp

      Affiliations

    • Lung Cell Biology, London SW3 6LY, UK
  • ,
  • Andrew J. Thorley

      Affiliations

    • Lung Cell Biology, London SW3 6LY, UK
  • ,
  • Jie Zhu

      Affiliations

    • Lung Pathology Unit, London SW3 6LY, UK
  • ,
  • Ann Dewar

      Affiliations

    • Electron Microscopy Unit, At National Heart & Lung Institute, Imperial College, London SW3 6LY, UK
  • ,
  • Peter K. Jeffery

      Affiliations

    • Lung Pathology Unit, London SW3 6LY, UK
  • ,
  • Teresa D. Tetley

      Affiliations

    • Lung Cell Biology, London SW3 6LY, UK

Received 22 August 2008; accepted 12 February 2009. published online 31 March 2009.

Summary 

Background

Myeloid and plasmacytoid dendritic cell (DC) subsets have been recently identified in the human lung based on their differential expression of Blood DC Antigens 1–3 (BDCAs). We investigated the expression of these antigens by isolated human pulmonary CD1a+ DCs, namely Langerhan's cells.

Methods

Using an in vitro cell culture system we successfully isolated a population of relatively pure (>70%) CD1a+ cells from human lung tissue (n=5 subject samples) and stained these with antibodies against the myeloid DC markers BDCA1 (CD1c) and BDCA3 (CD303), the plasmacytoid DC marker BDCA2 (CD141), the Langerhan's cell marker Langerin and the maturation marker CD83.

Results

Among different subject samples, the isolated CD1a+ cells showed variable expression of Langerin, BDCAs and CD83. Interestingly, in two subject samples, which contained >70% CD83+ mature CD1a+ cells, >50% of the cells were positive for all of the BDCAs.

Conclusions

We conclude that isolated pulmonary CD1a+ DCs in vitro have the capacity to express both myeloid and plasmacytoid BDCA markers and that rather than subset restriction in pulmonary DCs, a significant degree of flexibility/plasticity can be induced, albeit experimentally.

Keywords: Blood Dendritic Cell Antigen (BDCA), Dendritic cells, Langerhan's cells, Lung, Human

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0954-6111(09)00058-4

doi:10.1016/j.rmed.2009.02.006

Respiratory Medicine
Volume 103, Issue 6 , Pages 935-938, June 2009